Item 4.01: Changes in Registrant's Certifying Accountant – ResMed Inc. is reporting a change in its independent auditor/certifying accountant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers – The filing includes information regarding changes in company leadership, director elections,…

Our analysis rates this filing BULLISH. This Form 8-K discloses two routine corporate governance matters: an auditor transition and a planned board leadership succession. Both events are characterized by orderly processes, qualified successors, and absence of any disagreements or reportable issues.…

Concern level: LOW (1.8/10). Key factors: Auditor transition from KPMG to PwC introduces modest transition risk, though KPMG's clean audit opinion and absence of disagreements mitigate severity; Board leadership transition with Ron Taylor's retirement after 21 years, though successor Carol Burt is internally promoted with 13+ years tenure and relevant committee experience.

Notable risk changes: Auditor transition from KPMG to PwC - routine change with no audit disagreements or reportable events disclosed; Lead Director succession from Ron Taylor to Carol Burt - planned transition with internal promotion of experienced board member; No material financial, operational, or strategic risks disclosed in this 8-K.

The model predicts RMD will underperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.